Bio-Path Holdings (BPTH)
(Delayed Data from NSDQ)
$1.58 USD
+0.03 (1.94%)
Updated Jul 31, 2024 03:59 PM ET
After-Market: $1.58 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/20/24 |
---|---|
Current Quarter | -1.54 |
EPS Last Quarter | -4.88 |
Last EPS Surprise | -7.49% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.53 |
Next Year | -3.65 |
EPS (TTM) | -40.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.54 | -0.93 | -5.53 | -3.65 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -1.54 | -0.93 | -5.53 | -3.65 |
High Estimate | -1.54 | -0.93 | -5.53 | -3.65 |
Low Estimate | -1.54 | -0.93 | -5.53 | -3.65 |
Year ago EPS | -10.60 | -6.40 | -33.63 | -5.53 |
Year over Year Growth Est. | 85.47% | 85.47% | 83.56% | 34.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.54 | -0.93 | -5.53 | -3.65 |
7 Days Ago | -1.54 | -0.93 | -5.53 | -3.65 |
30 Days Ago | -1.54 | -0.93 | -5.53 | -3.65 |
60 Days Ago | -2.06 | -1.95 | -9.68 | -8.00 |
90 Days Ago | -4.60 | -4.71 | -18.71 | -18.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.54 | -0.93 | -5.53 | -3.65 |
Zacks Consensus Estimate | -1.54 | -0.93 | -5.53 | -3.65 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -4.88 | NA | -6.40 | -10.60 | NA |
Estimate | -4.54 | NA | -6.80 | -10.40 | NA |
Difference | -0.34 | NA | 0.40 | -0.20 | -0.05 |
Surprise | -7.49% | NA | 5.88% | -1.92% | -1.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more